Clinical Trial Update: Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations [Phase 1]

View source ↗

Summary

This Phase 1 trial compares the pharmacokinetic profiles of two nicotine gum formulations used for smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Nicotine Gum Formulation A (nicotine gum)
• Nicotine Gum Formulation B (nicotine gum)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED | Results posted: 2014-04-11